147 related articles for article (PubMed ID: 34864094)
1. CCL5 secreted by luminal B breast cancer cells induces polarization of M2 macrophages through activation of MEK/STAT3 signaling pathway via CCR5.
Zhu YY; Zhao YC; Chen C; Xie M
Gene; 2022 Feb; 812():146100. PubMed ID: 34864094
[TBL] [Abstract][Full Text] [Related]
2. Breast Phyllodes Tumors Recruit and Repolarize Tumor-Associated Macrophages via Secreting CCL5 to Promote Malignant Progression, Which Can Be Inhibited by CCR5 Inhibition Therapy.
Nie Y; Huang H; Guo M; Chen J; Wu W; Li W; Xu X; Lin X; Fu W; Yao Y; Zheng F; Luo ML; Saw PE; Yao H; Song E; Hu H
Clin Cancer Res; 2019 Jul; 25(13):3873-3886. PubMed ID: 30890553
[TBL] [Abstract][Full Text] [Related]
3. Autocrine CCL5 Effect Mediates Trastuzumab Resistance by ERK Pathway Activation in HER2-Positive Breast Cancer.
Zazo S; González-Alonso P; Martín-Aparicio E; Chamizo C; Luque M; Sanz-Álvarez M; Mínguez P; Gómez-López G; Cristóbal I; Caramés C; García-Foncillas J; Eroles P; Lluch A; Arpí O; Rovira A; Albanell J; Madoz-Gúrpide J; Rojo F
Mol Cancer Ther; 2020 Aug; 19(8):1696-1707. PubMed ID: 32404410
[TBL] [Abstract][Full Text] [Related]
4. Tunicamycin-induced ER stress regulates chemokine CCL5 expression and secretion via STAT3 followed by decreased transmigration of MCF-7 breast cancer cells.
Zhang Y; Liao S; Fan W; Wei W; Wang C; Sun S
Oncol Rep; 2014 Dec; 32(6):2769-76. PubMed ID: 25231320
[TBL] [Abstract][Full Text] [Related]
5. Blocking the CCL5-CCR5 Axis Using Maraviroc Promotes M1 Polarization of Macrophages Cocultured with Irradiated Hepatoma Cells.
Zhuang Y; Zhao X; Yuan B; Zeng Z; Chen Y
J Hepatocell Carcinoma; 2021; 8():599-611. PubMed ID: 34178876
[TBL] [Abstract][Full Text] [Related]
6. Co-culture of ovarian cancer stem-like cells with macrophages induced SKOV3 cells stemness via IL-8/STAT3 signaling.
Ning Y; Cui Y; Li X; Cao X; Chen A; Xu C; Cao J; Luo X
Biomed Pharmacother; 2018 Jul; 103():262-271. PubMed ID: 29656182
[TBL] [Abstract][Full Text] [Related]
7. CCL5 secreted by tumor associated macrophages may be a new target in treatment of gastric cancer.
Ding H; Zhao L; Dai S; Li L; Wang F; Shan B
Biomed Pharmacother; 2016 Feb; 77():142-9. PubMed ID: 26796278
[TBL] [Abstract][Full Text] [Related]
8. Induction of copper/zinc-superoxide dismutase by CCL5/CCR5 activation causes tumour necrosis factor-alpha and reactive oxygen species production in macrophages.
Qiu L; Ding L; Huang J; Wang D; Zhang J; Guo B
Immunology; 2009 Sep; 128(1 Suppl):e325-34. PubMed ID: 19016906
[TBL] [Abstract][Full Text] [Related]
9. Chemokine C-C motif receptor 5 and C-C motif ligand 5 promote cancer cell migration under hypoxia.
Lin S; Wan S; Sun L; Hu J; Fang D; Zhao R; Yuan S; Zhang L
Cancer Sci; 2012 May; 103(5):904-12. PubMed ID: 22380870
[TBL] [Abstract][Full Text] [Related]
10. Tumor-derived lactate induces M2 macrophage polarization via the activation of the ERK/STAT3 signaling pathway in breast cancer.
Mu X; Shi W; Xu Y; Xu C; Zhao T; Geng B; Yang J; Pan J; Hu S; Zhang C; Zhang J; Wang C; Shen J; Che Y; Liu Z; Lv Y; Wen H; You Q
Cell Cycle; 2018; 17(4):428-438. PubMed ID: 29468929
[TBL] [Abstract][Full Text] [Related]
11. Blocking Interleukin (IL)4- and IL13-Mediated Phosphorylation of STAT6 (Tyr641) Decreases M2 Polarization of Macrophages and Protects Against Macrophage-Mediated Radioresistance of Inflammatory Breast Cancer.
Rahal OM; Wolfe AR; Mandal PK; Larson R; Tin S; Jimenez C; Zhang D; Horton J; Reuben JM; McMurray JS; Woodward WA
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):1034-1043. PubMed ID: 29485045
[TBL] [Abstract][Full Text] [Related]
12. The RNA-binding protein HuR inhibits expression of CCL5 and limits recruitment of macrophages into tumors.
Brauß TF; Winslow S; Lampe S; Scholz A; Weigert A; Dehne N; von Stedingk K; Schmid T; Brüne B
Mol Carcinog; 2017 Dec; 56(12):2620-2629. PubMed ID: 28731284
[TBL] [Abstract][Full Text] [Related]
13. Genistein inhibits stemness of SKOV3 cells induced by macrophages co-cultured with ovarian cancer stem-like cells through IL-8/STAT3 axis.
Ning Y; Feng W; Cao X; Ren K; Quan M; Chen A; Xu C; Qiu Y; Cao J; Li X; Luo X
J Exp Clin Cancer Res; 2019 Jan; 38(1):19. PubMed ID: 30646963
[TBL] [Abstract][Full Text] [Related]
14. The potential to target CCL5/CCR5 in breast cancer.
Velasco-Velázquez M; Xolalpa W; Pestell RG
Expert Opin Ther Targets; 2014 Nov; 18(11):1265-75. PubMed ID: 25256399
[TBL] [Abstract][Full Text] [Related]
15. The prognostic value of quantitative analysis of CCL5 and collagen IV in luminal B (HER2-) subtype breast cancer by quantum-dot-based molecular imaging.
Zhu YY; Chen C; Li JJ; Sun SR
Int J Nanomedicine; 2018; 13():3795-3803. PubMed ID: 29988769
[TBL] [Abstract][Full Text] [Related]
16. Cancer cell CCL5 mediates bone marrow independent angiogenesis in breast cancer.
Sax MJ; Gasch C; Athota VR; Freeman R; Rasighaemi P; Westcott DE; Day CJ; Nikolic I; Elsworth B; Wei M; Rogers K; Swarbrick A; Mittal V; Pouliot N; Mellick AS
Oncotarget; 2016 Dec; 7(51):85437-85449. PubMed ID: 27863423
[TBL] [Abstract][Full Text] [Related]
17. CCL5-Mediated Th2 Immune Polarization Promotes Metastasis in Luminal Breast Cancer.
Zhang Q; Qin J; Zhong L; Gong L; Zhang B; Zhang Y; Gao WQ
Cancer Res; 2015 Oct; 75(20):4312-21. PubMed ID: 26249173
[TBL] [Abstract][Full Text] [Related]
18. PAI-1 induces Src inhibitor resistance via CCL5 in HER2-positive breast cancer cells.
Fang H; Jin J; Huang D; Yang F; Guan X
Cancer Sci; 2018 Jun; 109(6):1949-1957. PubMed ID: 29601121
[TBL] [Abstract][Full Text] [Related]
19. Ovarian cancer stem-like cells differentiate into endothelial cells and participate in tumor angiogenesis through autocrine CCL5 signaling.
Tang S; Xiang T; Huang S; Zhou J; Wang Z; Xie R; Long H; Zhu B
Cancer Lett; 2016 Jun; 376(1):137-47. PubMed ID: 27033454
[TBL] [Abstract][Full Text] [Related]
20. Basal-like breast cancer cells induce phenotypic and genomic changes in macrophages.
Stewart DA; Yang Y; Makowski L; Troester MA
Mol Cancer Res; 2012 Jun; 10(6):727-38. PubMed ID: 22532586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
